Skip to content

DNAlytics: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

DNAlytics

BE 0844.973.235
NACE 72.101, Research and development on biotechnology
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€118,905
2024 · €201,962-€83,057
Equity
€502,481
2024 · €383,576+€118,905
Cash
€113,871
2024 · €262,294-€148,423
Balance sheet total
€849,953
2024 · €898,685-€48,732

Largest movements

2024 to 2025
Assets
  • Cash -€148,423

    down €148,423 (-56.6%), from €262,294 to €113,871

    mainly Investment in fixed assets (net) (-€310,460) and Debts after one year (-€198,094)

  • Intangible fixed assets +€115,263

    up €115,263 (+29.3%), from €393,698 to €508,960

  • Receivables within one year -€14,228

    down €14,228 (-7.4%), from €191,702 to €177,475

    of which Trade receivables: -€30,853

Equity and liabilities
  • Debts after one year -€198,094

    down €198,094 (-64.0%), from €309,670 to €111,576

    of which Other amounts payable: -€133,230

  • Profit (loss) carried forward +€118,905

    up €118,905 (+67.6%), from €175,794 to €294,699

  • Accrued charges and deferred income +€38,621

    new in 2025: €38,621

  • Tax, wage and social debts -€21,855

    down €21,855 (-16.4%), from €133,020 to €111,165

    of which Remuneration and social security: -€34,641

  • Short-term financial debts +€9,172

    up €9,172 (+20.4%), from €44,858 to €54,030

Income statement
  • Depreciation +€57,945

    up €57,945 (+41.8%), from €138,522 to €196,467

  • Staff costs +€15,302

    up €15,302 (+3.1%), from €490,303 to €505,605

  • Gross operating margin -€10,771

    down €10,771 (-1.3%), from €845,970 to €835,200

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €201,962
Gross operating margin -€10,771
Staff costs -€15,302
Depreciation -€57,945
Other operating charges +€47
Financial income +€16
Financial charges +€928
Taxes -€31
Result 2025 €118,905

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€350,959
Investment -€310,460
Financing -€188,922
Cash 2024 €262,294
Net result for the year +€118,905
Depreciation +€196,467
Receivables within one year +€14,228
Deferred charges and accrued income +€74
Trade debts +€6,194
Tax, wage and social debts -€21,855
Other debts -€1,675
Accrued charges and deferred income +€38,621
Investment in fixed assets (net) -€310,460
Debts after one year -€198,094
Short-term financial debts +€9,172
Cash 2025 €113,871
Every line side by side 51 lines
Line Code 2024 2025 Change %
Total assets 20/58 €898,685 €849,953 -€48,732 -5.4%
Fixed assets 21/28 €409,404 €523,398 +€113,993 +27.8%
Intangible fixed assets 21 €393,698 €508,960 +€115,263 +29.3%
Tangible fixed assets 22/27 €6,389 €4,949 -€1,439 -22.5%
Plant, machinery and equipment 23 €6,389 €4,949 -€1,439 -22.5%
Financial fixed assets 28 €9,318 €9,488 +€170 +1.8%
Current assets 29/58 €489,280 €326,555 -€162,725 -33.3%
Amounts receivable within one year 40/41 €191,702 €177,475 -€14,228 -7.4%
Trade receivables 40 €191,702 €160,849 -€30,853 -16.1%
Other amounts receivable 41 - €16,626 +€16,626
Cash at bank and in hand 54/58 €262,294 €113,871 -€148,423 -56.6%
Deferred charges and accrued income 490/1 €35,284 €35,210 -€74 -0.2%
Total equity and liabilities 10/49 €898,685 €849,953 -€48,732 -5.4%
Equity 10/15 €383,576 €502,481 +€118,905 +31.0%
Contributions 10/11 €207,000 €207,000 = 0.0%
Capital 10 €207,000 - -€207,000
Issued capital 100 €207,000 - -€207,000
Outside capital 11 - €207,000 +€207,000
Other 1109/19 - €207,000 +€207,000
Reserves 13 €782 €782 = 0.0%
Non-distributable reserves 130/1 €782 €782 = 0.0%
Legal reserve 130 €782 - -€782
Reserves not available under the articles 1311 - €782 +€782
Profit (loss) carried forward 14 €175,794 €294,699 +€118,905 +67.6%
Amounts payable 17/49 €515,108 €347,472 -€167,637 -32.5%
Amounts payable after more than one year 17 €309,670 €111,576 -€198,094 -64.0%
Financial debts 170/4 €104,817 €39,952 -€64,864 -61.9%
Other amounts payable 178/9 €204,853 €71,624 -€133,230 -65.0%
Amounts payable within one year 42/48 €205,439 €197,275 -€8,164 -4.0%
Financial debts 43 €44,858 €54,030 +€9,172 +20.4%
Other loans 439 €44,858 €54,030 +€9,172 +20.4%
Trade debts 44 €19,943 €26,136 +€6,194 +31.1%
Suppliers 440/4 €19,943 €26,136 +€6,194 +31.1%
Taxes, remuneration and social security 45 €133,020 €111,165 -€21,855 -16.4%
Taxes 450/3 €24,738 €37,524 +€12,787 +51.7%
Remuneration and social security 454/9 €108,282 €73,641 -€34,641 -32.0%
Other amounts payable 47/48 €7,618 €5,943 -€1,675 -22.0%
Accrued charges and deferred income 492/3 - €38,621 +€38,621
Remuneration, social security and pensions 62 €490,303 €505,605 +€15,302 +3.1%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €138,522 €196,467 +€57,945 +41.8%
Other operating charges 640/8 €457 €410 -€47 -10.3%
Gross operating margin 9900 €845,970 €835,200 -€10,771 -1.3%
Operating profit (loss) 9901 €216,688 €132,718 -€83,970 -38.8%
Financial income 75/76B €1 €17 +€16 +1321.3%
Recurring financial income 75 €1 €17 +€16 +1321.3%
Financial charges 65/66B €13,059 €12,131 -€928 -7.1%
Recurring financial charges 65 €13,059 €12,131 -€928 -7.1%
Profit (loss) for the period before taxes 9903 €203,630 €120,604 -€83,026 -40.8%
Income taxes 67/77 €1,668 €1,699 +€31 +1.8%
Profit (loss) for the period 9904 €201,962 €118,905 -€83,057 -41.1%
Profit (loss) for the period to be appropriated 9905 €201,962 €118,905 -€83,057 -41.1%

Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 7 October 2026 via checked.be.